Tirzepatide's greater glucose-lowering effect compared to semaglutide means hypoglycemia risk may increase, especially if you are also taking sulfonylureas or insulin
Key Points Weight loss diabetes drugs like Ozempic, Wegovy (semaglutide), Zepbound, and Mounjaro have been linked to rare vision issues Research on people taking semaglutide (Ozempic and Wegovy) showed an increased risk of NAION (a type of eye nerve stroke) and other serious eye conditions NAION risk is very rare, affecting up to 1 in 10,000 people taking semaglutide, according to the European Medicines Agency (EMA) There is no conclusive proof that the medications are a direct cause of vision problems If you experience any vision changes or issues, please get medical care immediately and let your healthcare provider know about your symptoms Medications like Ozempic, Wegovy, Zepbound, and Mounjaro changed how many people manage type 2 diabetes and weight gain
The FDAs compounding policy update is available here
Understanding how dosage affects cost can save you hundreds of dollars over a treatment course
The Phase 3 data at 68 weeks showed continued weight loss at a rate that suggested the plateau, if it exists, lies beyond 68 weeks
